Anti-hepatitis B activity of (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether derivatives

The (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether derivative designed by combining oxime ether and isoxazoline functional groups has solved the low efficacy of existing anti-hepatitis B drugs. and drug resistance issues, demonstrated the effective inhibitory effect and low toxicity of HBV, and has the potential to become a new anti-hepatitis B drug.

CN116143718BActive Publication Date: 2024-12-06GUANGXI UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111386868.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-11-22
Publication Date
2024-12-06
Estimated Expiration
2041-11-22

AI Technical Summary

Technical Problem

Existing anti-hepatitis B virus drugs such as interferon and nucleoside analogs have low efficacy, large side effects, long course of treatment and drug resistance, and lack effective new anti-hepatitis B drugs.

Method used

Develop an anti-hepatitis B activity (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether derivative, and design the oxime ether by combining the isoxazoline functional group. Compounds with anti-hepatitis B virus activity were prepared by specific synthetic methods to demonstrate their inhibitory effects on HBV surface antigen and HBVe antigen.

Benefits of technology

In HepG2.2.15 cell experiments, this compound showed that the inhibition rate of HBVe antigen was higher than that of lamivudine, and it was low toxicity, and had the potential to become a novel non-nucleoside anti-hepatitis B virus drug.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FHA0000006660700000011
    Figure FHA0000006660700000011
  • Figure GHA0000006703150000011
    Figure GHA0000006703150000011
  • Figure GHA0000006703150000012
    Figure GHA0000006703150000012
Patent Text Reader

Abstract

The present invention discloses an anti-hepatitis B activity (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether derivative. Through HepG2.2.15 cell experiments, it was found that these oxime ether derivatives had a certain inhibitory effect on HBVe antigen (HBeAg) and HBV surface antigen (HBsAg), and the lamivudine inhibition rate on HBeAg under the same conditions was only 72.02%, while the (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether derivatives had an inhibition rate of up to 82.39% on HBeAg, and had the characteristics of low toxicity. Therefore, the oxime ether derivatives of the general formula of the present invention can be used as non-nucleoside anti-hepatitis B virus active molecules, and are expected to become new anti-hepatitis B virus drugs, which are of great significance to the research on anti-hepatitis B virus drugs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to oxime ether compounds, and in particular relates to an anti-hepatitis B active (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether derivative. Background Art

[0002] Viral hepatitis type B (HBV) is a common infectious disease caused by the hepatitis B virus (HBV). The liver diseases it causes (such as acute and chronic hepatitis B, cirrhosis, and liver cancer) have become a major challenge threatening the world's public health security.

[0003] At present, the main method for treating hepatitis B is to prevent HBV-related liver damage and hepatitis from deteriorating to advanced liver diseases such as cirrhosis and liver cancer, among which antiviral drugs are the key. At present, there are two major categories of antiviral drugs, interferon and nucleoside analogs. However, interferon has a low response rate and large side effects, and nucleoside antiviral drugs also have disadvantages such as long treatment course, easy to develop drug resistance and drug withdrawal rebound. Therefore, exploring and developing new anti-hepatitis B drugs with new structures has great medical significance.

[0004] Oxime ether and isoxazoline functional groups are widely present in natural and synthetic drug molecules and are often used in the development of pesticides, but examples of combining the two functional groups for drug molecule design have rarely been reported. Summary of the invention

[0005] The technical problem to be solved by the present invention is to provide an anti-hepatitis B activity (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether derivative, which has important research and application value in the preparation of anti-hepatitis B virus drugs.

[0006] In order to solve the above technical problems, the present invention adopts the following technical solutions:

[0007] The (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether derivative with anti-hepatitis B activity is one of the compounds having the following general formula:

[0008]

[0009] Wherein, R1, R2 are H, F, Cl, OCH3 or OCH2O; R3 is H or Cl; R4, R5 are H, F, Cl, OCH3 or

[0010] CH3.

[0011] The above-mentioned oxime ether derivative is one of the following compounds:

[0012]

[0013]

[0014] The preparation method of the above oxime ether derivatives comprises the following steps:

[0015] 1) The preparation of aromatic aldehyde oxime (2a-2f) is carried out according to the following reaction formula:

[0016]

[0017] 2) The preparation of chloroaromatic aldehyde oxime (3a-3f) is carried out according to the following reaction formula:

[0018]

[0019] 3) Preparation of aryl acetone oxime (2g-2k) and O-propargyl aryl acetone oxime ether (3g-3k) according to the following reaction formula:

[0020]

[0021] 4) The preparation of (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether compounds (4a-4o) is carried out according to the following reaction formula:

[0022]

[0023] Step 1) The following operation was performed: 1 equivalent (5 mmol) of aromatic aldehyde (1a-1f) was dissolved in 80% ethanol-water, stirred until the solution was clear, then 1.5 equivalents of hydroxylamine hydrochloride (7.5 mmol) was added, stirred evenly, and then 1.5 equivalents of sodium carbonate (7.5 mmol) was added in three batches. At this time, the solution pH was 8-9, stirred at room temperature for 6 h, and the TLC was followed (V 石油醚 :V 乙酸乙酯 =5:1), after the reaction, add 50 ml of water, neutralize with dilute hydrochloric acid to neutrality, extract with 3×30 ml of ethyl acetate, combine the organic phases, wash with saturated brine 3 times, dry with excess anhydrous sodium sulfate for 2 h, filter and evaporate the solvent to obtain the target aromatic aldehyde oxime (2a-2f), which is directly used in the next step without separation.

[0024] Step 2) The following operation was performed: 1 equivalent (5 mmol) of aromatic aldehyde oxime (2a-2f) was dissolved in 10 ml of DMF and stirred until the solution was clear. Then 2.5 equivalents (7.5 mmol) of N-chlorosuccinimide (NCS) were added under ice bath and stirred for 6 h at room temperature. The reaction mixture was followed by thin layer chromatography (V 石油醚 :V 乙酸乙酯=10:1), after the reaction, add 50 ml of ice water, extract with 3×30 ml of ether, combine the organic phases, wash with saturated brine 3 times, dry with excess anhydrous sodium sulfate for 2 h, filter and evaporate the solvent to obtain the target chloroaromatic aldehyde oxime (3a-3f), which is directly used in the next step without separation.

[0025] Step 3) is performed as follows: the method in step 1) is used to prepare aryl acetonide oxime (2g-2k), 1 equivalent (6mmol) of aryl acetonide oxime (2g-2k) is dissolved in 15ml of acetonitrile, 1.5 equivalents of propargyl bromide (7.5mmol) and 1.5 equivalents of sodium hydroxide (7.5mmol) are added, and the mixture is heated to reflux for 8h, and the mixture is tracked by thin layer chromatography (V 石油醚 :V 乙酸乙酯 =20:1), after the reaction was completed, cooled to room temperature, 100 ml of water was added to acetonitrile, extracted with 3×30 ml of ethyl acetate, washed 3 times with saturated brine, dried over anhydrous sodium sulfate, filtered and evaporated, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =20:1) to obtain the pure product (3g-3k).

[0026] Step 4) The following operation was performed: 1 equivalent (1 mmol) of chloroaromatic aldehyde oxime (3a-3f) and 5% mmol of copper acetate dihydrate were dissolved in 15 ml of 1,4-dioxane, and 1.5 equivalents of triethylamine (1.5 mmol) were added under nitrogen atmosphere. The mixture was stirred at room temperature for 15 min to obtain a large amount of light blue solid. Then, a 2 ml 1,4-dioxane solution of O-propargyl aryl ketone oxime ether (3g-3k) was slowly added dropwise with a syringe. After the addition was completed, the mixture was heated to reflux for 2 h and tracked by thin layer chromatography (V 石油醚 :V 乙酸乙酯 =10:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =10:1), and recrystallized from ethanol-dichloromethane to obtain pure (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether compounds (4a-4o).

[0027] Application of the above oxime ether derivatives in the preparation of anti-hepatitis B virus drugs.

[0028] The inventors combined oxime ether and isoxazoline functional groups to design drug molecules, and developed an anti-hepatitis B active (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether derivative, which is one of the compounds with the following general formula:

[0029]

[0030] Through HepG2.2.15 cell experiments, it was found that these oxime ether derivatives have a certain inhibitory effect on HBVe antigen (HBeAg) and HBV surface antigen (HBsAg). Under the same conditions, the inhibition rate of lamivudine on HBeAg is only 72.02%, while the inhibition rate of (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether derivatives on HBeAg can reach up to 82.39%, and has the characteristics of low toxicity. Therefore, the oxime ether derivatives of the general formula of the present invention can be used as non-nucleoside anti-hepatitis B virus active molecules, and are expected to become new anti-hepatitis B virus drugs, which is of great significance for the research of anti-hepatitis B virus drugs. DETAILED DESCRIPTION

[0031] To further illustrate how to implement the present invention, compounds 4a-4o are prepared by referring to the preparation method of (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether derivatives in the above invention content.

[0032] Example 1

[0033] Dissolve 1 equivalent (2 mmol) of chloroaromatic aldehyde oxime 3a and 5% mmol of copper acetate dihydrate in 15 ml of 1,4-dioxane. Add 1.5 equivalents of triethylamine (3 mmol) under nitrogen atmosphere. Stir at room temperature for 15 min to produce a large amount of light blue solid. Then slowly add 1 equivalent (2 mmol) of 1-phenylethane-1-one-O-propargyl oxime ether 3g in 2 ml of 1,4-dioxane solution dropwise with a syringe. After the addition is completed, heat under reflux for 2 h. TLC tracking (V 石油醚 :V 乙酸乙酯 =10:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =10:1), and recrystallized from ethanol-dichloromethane to give a pale yellow solid (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether 4a, 0.51 g, yield 88%.

[0034] The Chinese name of the compound in Example 1: (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether.

[0035] English name: (E)-1-phenylethan-1-one O-((3-phenylisoxazol-5-yl)methyl)oxime

[0036] Structural formula:

[0037]

[0038] Molecular formula: C 18 H 16 N2O2 molecular weight: 292.1297;

[0039] Physical and chemical properties: Pale yellow solid, melting point 69.6-70.5℃. Soluble in chloroform, ethyl acetate, acetone, methanol, ethanol, hardly soluble in water;

[0040] NMR data 1 H NMR (600MHz, CDCl3) δ7.84 (dd, J=7.4, 2.3Hz, 2H, H 14 or H 18 ),7.70–7.65(m,2H,H3 or H5),7.48–7.43(m,3H,H 15 ,H 17 and H 16 ),7.41–7.36(m,3H,H2 andH6),6.63(s,1H, 11 ),5.35(s,2H,H9),2.31(s,3H,H8). 13 C NMR (151 MHz, CDCl3) δ 169.87 (C 10 ),162.47(C 12 ),156.46(C7),136.07(C4),130.04(C 16 ),129.50(C1),129.09(C 13 ),128.95(C 15 or C 17 ),128.51(C2 or C6),126.91(C 14 or C 18 ),126.24(C3 or C5),101.49(C 11 ), 66.70(C9), 12.94(C8). Mass spectral data HRESIMS: m / z 293.1297[M+H] + .

[0041] Example 2

[0042] Dissolve 1 equivalent (2 mmol) of chloroaromatic aldehyde oxime 3a and 5% mmol of copper acetate dihydrate in 15 ml of 1,4-dioxane. Add 1.5 equivalents of triethylamine (3 mmol) under nitrogen atmosphere. Stir at room temperature for 15 min to produce a large amount of light blue solid. Then slowly add 1 equivalent (2 mmol) of 1-(3,4-dimethoxy)phenylethane-1-one-O-propargyl oxime ether 3i in 2 ml of 1,4-dioxane solution with a syringe. After the addition is completed, heat to reflux for 2 h. TLC tracking (V 石油醚 :V 乙酸乙酯 =10:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =10:1), and recrystallized from ethanol-dichloromethane to give a pale yellow solid (E)-(3-phenylisoxazole-5-)-methylene-(3,4-dimethoxyphenyl)ethanone oxime ether 4b, 0.58 g, yield 83%.

[0043] The Chinese name of the compound in Example 2: (E)-(3-phenylisoxazole-5-)-methylene-(3,4-dimethoxyphenyl)ethanone oxime ether.

[0044] English name: (E)-1-(3,4-dimethoxyphenyl)ethan-1-one O-((3-phenylisoxazol-5-yl)methyl)oxime

[0045] Structural formula:

[0046]

[0047] Molecular formula: C 20 H 20 N2O4 molecular weight: 352.1507;

[0048] Physical and chemical properties: white solid, melting point 93.8-94.5℃. Soluble in chloroform, ethyl acetate, acetone, methanol, ethanol, hardly soluble in water;

[0049] NMR data 1 H NMR(400MHz, CDCl3)δ7.82–7.78(m,2H,H 16 or H 20 ),7.46–7.41(m,3H,H 17 ,H 19 and H 18),7.28(d,J=2.1Hz,1H,H6),7.15(dd,J=8.4,2.1Hz,1H,H4),6.84(d,J=8.4Hz,1H,H3),6.60(s,1H,H 13 ),5.32(s,2H,H 11 ),3.90(s,3H,H1 or H8),3.88(s,3H,H1 or H8),2.26(s,3H,H 10 ). 13 C NMR (101 MHz, CDCl3) δ 169.98 (C 12 ),162.46(C 14 ),156.00(C9),150.42(C2),148.90(C7),130.06(C 18 ),129.07(C 15 ),128.96(C 17 or C 19 ),128.77(C5),126.87(C 16 or C 20 ),119.45(C4),110.62(C3),108.76(C6),101.40(C 13 ),66.69(C 11 ),55.97(C1 or C8),55.95(C1 or C8),12.82(C 10 ).Mass spectrum data HRESIMS: m / z 353.1507[M+H] + .

[0050] Example 3

[0051] 1 equivalent (2 mmol) of chloroaromatic aldehyde oxime 3a and 5% mmol of copper acetate dihydrate were dissolved in 15 ml of 1,4-dioxane. 1.5 equivalents of triethylamine (3 mmol) were added under nitrogen atmosphere. The mixture was stirred at room temperature for 15 min to produce a large amount of light blue solid. Then, 1 equivalent (2 mmol) of 1-(4-chlorophenyl)ethane-1-one-O-propargyl oxime ether 3j in 2 ml of 1,4-dioxane solution was slowly added dropwise with a syringe. After the addition was completed, the mixture was heated to reflux for 2 h. The reaction mixture was followed by thin layer chromatography (V 石油醚 :V 乙酸乙酯 =10:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯=10:1), and recrystallized from ethanol-dichloromethane to give a pale yellow solid (E)-(3-phenylisoxazole-5-)-methylene-(4-chlorophenyl)ethanone oxime ether 4c, 0.56 g, yield 87%.

[0052] The Chinese name of the compound in Example 3: (E)-(3-phenylisoxazole-5-)-methylene-(4-chlorophenyl)ethanone oxime ether.

[0053] English name: (E)-1-(4-chlorophenyl)ethan-1-one O-((3-phenylisoxazol-5-yl)meth yl)oxime

[0054] Structural formula:

[0055]

[0056] Molecular formula: C 18 H 15 ClN2O2 molecular weight: 326.0905;

[0057] Physical and chemical properties: white rod-shaped crystals, melting point 106.8-107.1°C. Soluble in chloroform, ethyl acetate, acetone, methanol, ethanol, and insoluble in water;

[0058] NMR data 1 H NMR(400MHz,CDCl3)δ7.83–7.77(m,2H,H 14 or H 18 ),7.58(d,J=8.5Hz,2H,H3 or H5),7.44–7.42(m,3H,H 15 ,H 17 and H 16 ),7.33(d,J=8.5Hz,2H,H2 or H6),6.59(s,1H,H 11 ),5.32(s,2H,H9),2.25(s,3H,H8). 13 C NMR (101 MHz, CDCl3) δ 169.60 (C 10 ),162.43(C 12 ),155.28(C7),135.47(C1),134.42(C4),130.02(C 16 ),128.98(C 13 ),128.90(C 15 or C 17 ),128.64(C2 or C6),127.45(C3 or C5),126.84(C14 or C 18 ),101.48(C 11 ),66.71(C9),12.70(C8). Mass spectral data HRESIMS:m / z

[0059] 327.0905[M+H] + .

[0060] Example 4

[0061] Dissolve 1 equivalent (2 mmol) of chloroaromatic aldehyde oxime 3b and 5% mmol of copper acetate dihydrate in 15 ml of 1,4-dioxane. Add 1.5 equivalents of triethylamine (3 mmol) under nitrogen atmosphere. Stir at room temperature for 15 min to produce a large amount of light blue solid. Then slowly add 1 equivalent (2 mmol) of 1-(4-dimethoxy)phenylethane-1-one-O-propargyl oxime ether 3h in 2 ml of 1,4-dioxane solution with a syringe. After the addition is completed, heat and reflux for 2 h. TLC tracking (V 石油醚 :V 乙酸乙酯 =10:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =10:1), and recrystallized from ethanol-dichloromethane to give a pale yellow solid (E)-(3-(3-chloro-4-methoxyphenylisoxazole-5-)-methylene-(4-methoxyphenyl)ethanone oxime ether 4d, 0.65 g, yield 88%.

[0062] The Chinese name of the compound of Example 4: (E)-(3-(3-chloro-4-methoxyphenylisoxazole-5-)-methylene-(4-methoxyphenyl)ethanone oxime ether.

[0063] English name: (E)-1-(4-methoxyphenyl)ethan-1-one O-((3-(3-chloro-4-methoxyphenyl)isoxazol-5-yl)methyl)oxime

[0064] Structural formula:

[0065]

[0066] Molecular formula: C 20 H 19 ClN2O4 molecular weight: 386.1116;

[0067] Physical and chemical properties: white crystals, melting point 135.4-136.2℃. Soluble in chloroform, ethyl acetate, acetone, methanol, ethanol, hardly soluble in water;

[0068] NMR data 1 H NMR (400MHz, CDCl3) δ7.82 (d, J = 2.2Hz, 1H, H 19 ),7.68(dd,J=8.6,2.2Hz,1H,H 15 ),7.59(d,J=8.8Hz,2H,H4 or H6),6.96(d,J=8.6Hz,1H,H 16 ),6.87(d,J=8.8Hz,2H,H3 or H7),6.53(s,1H,H 12 ),5.28(s,2H,H 10 ),3.92(s,3H,H 10 ),3.80(s,3H,H 20 ),2.25(s,3H,H9). 13 C NMR (126MHz,CDCl3)δ170.15(C 11 ),161.05(C 13 ),160.68(C2),156.25(C 17 ),155.99(C8),128.73(C 19 ),128.47(C5),127.55(C4 or C6),126.40(C 15 ),123.00(C 14 ),122.44(C 18 ),113.82(C3 or C7),112.10(C 16 ),101.01(C 12 ),66.55(C 10 ),56.25(C 20 ),55.33(C1),12.80(C9). Mass spectral data HRESIMS:m / z 387.1116[M+H] + .

[0069] Example 5

[0070] Dissolve 1 equivalent (2 mmol) of chloroaromatic aldehyde oxime 3c and 5% mmol of copper acetate dihydrate in 15 ml of 1,4-dioxane. Add 1.5 equivalents of triethylamine (3 mmol) under nitrogen atmosphere. Stir at room temperature for 15 min to produce a large amount of light blue solid. Then slowly add 1 equivalent (2 mmol) of (E)-1-(3,4-dimethoxyphenyl)ethan-1-one O-propynyl-1-yl oxime 3i in 2 ml of 1,4-dioxane solution with a syringe. After the addition is completed, heat to reflux for 2 h. TLC tracking (V 石油醚 :V 乙酸乙酯 =5:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =5:1), and recrystallized from ethanol-dichloromethane to obtain a white powder (E)-(3-(2-chloro-4,5-dimethoxyphenyl)isoxazole-5-)-methylene-(3,4-dimethoxyphenyl)ethanone oxime ether 4e, 0.74 g, yield 80%.

[0071] The Chinese name of the compound of Example 5: (E)-(3-(2-chloro-4,5-dimethoxyphenyl)isoxazole-5-)-methylene-(3,4-dimethoxyphenyl)ethanone oxime ether.

[0072] English name: (E)-1-(3,4-dimethoxyphenyl)ethan-1-one O-((3-(2-chloro-4,5-dimet hoxyphenyl)isoxazol-5-yl)methyl)oxime

[0073] Structural formula:

[0074]

[0075] Molecular formula: C 22 H 23 ClN2O6 molecular weight: 446.1331;

[0076] Physical and chemical properties: white powder, melting point 127.3-128.2℃. Soluble in chloroform, ethyl acetate, acetone, methanol, ethanol, hardly soluble in water;

[0077] NMR data 1 H NMR(400MHz,CDCl3)δ7.28(s,1H,H 16),7.27(d,J=2.0Hz,1H,H6),7.13(dd,J=8.4,2.0Hz,1H,H4),6.91(s,1H,H 19 ),6.84–6.80(m,2H,H3 or H 13 ),5.31(s,2H,H 11 ),3.90–3.86(m,12H,H1,H8,H 21 and H 22 ),2.24(s,3H,H 10 ). 13 C NMR (101 MHz, CDCl3) δ 169.08 (C 12 ),160.91(C 14 ),155.99(C9),150.62(C 18 ),150.40(C2),148.88(C7),148.03(C 17 ),128.79(C5),124.55(C 20 ),120.04(C 15 ),119.44(C4),113.10(C 19 ),112.69(C 16 ),110.58(C6),108.71(C3),104.77(C 13 ),66.56(C 11 ),56.27(C 21 or C 22 ),56.25(C 21 or C 22 ),55.96(C1 orC8),55.94(C1 or C8),12.82(C 10 ).Mass spectrum data HRESIMS: m / z 447.1331[M+H] + .

[0078] Example 6

[0079] Dissolve 1 equivalent (2 mmol) of chloroaromatic aldehyde oxime 3c and 5% mmol of copper acetate dihydrate in 15 ml of 1,4-dioxane. Add 1.5 equivalents of triethylamine (3 mmol) under nitrogen atmosphere. Stir at room temperature for 15 min to produce a large amount of light blue solid. Then slowly add 1 equivalent (1 mmol) of (E)-1-(4-fluorophenyl)ethan-1-one O-propynyl-1-yl oxime 3k in 2 ml of 1,4-dioxane solution with a syringe. After the addition is completed, heat to reflux for 2 h. TLC tracking (V 石油醚 :V 乙酸乙酯=10:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =10:1), and recrystallized from ethanol-dichloromethane to give a white powder (E)-(3-(2-chloro-4,5-dimethoxyphenyl)isoxazole-5-)-methylene-(4-chlorophenyl)ethanone oxime ether 4f, 0.71 g, yield 84%.

[0080] The Chinese name of the compound of Example 6: (E)-(3-(2-chloro-4,5-dimethoxyphenyl)isoxazole-5-)-methylene-(4-chlorophenyl)ethanone oxime ether.

[0081] English name: (E)-1-(4-chlorophenyl)ethan-1-one O-((3-(2-chloro-4,5-dimethoxyp henyl)isoxazol-5-yl)methyl)oxime

[0082] Structural formula:

[0083]

[0084] Molecular formula: C 20 H 18 Cl2N2O4 molecular weight: 420.0714;

[0085] Physical and chemical properties: white powder, melting point 96.7-97.5℃. Soluble in chloroform, ethyl acetate, acetone, methanol, ethanol, hardly soluble in water;

[0086] NMR data 1 H NMR (400MHz, CDCl3) δ7.58 (d, J=8.6Hz, 2H, H3 or H5), 7.32 (d, J=8.6Hz, 2H, H2 or H6), 7.30 (s, 1H, H 14 ),6.93(s,1H,H 17 ),6.84(s,1H,H 11 ),5.33(s,2H,H9),3.90(s,6H,H 19 or H 20 ),2.25(s,3H,H8). 13 C NMR (101 MHz, CDCl3) δ 168.69 (C 10 ),160.87(C 12 ),155.23(C7),150.61(C16 ),148.00(C 15 ),135.43(C1),134.43(C4),128.61(C2 or C6),127.44(C3 or C5),124.53(C 18 ),119.95(C 13 ),113.08(C 17 ),112.66(C 14 ),104.86(C 11 ),66.60(C9),56.21(C 19 or C 20 ),56.19(C 19 or C 20 ),12.69(C8).Mass spectrum data HRESIMS:m / z421.0714[M+H] + .

[0087] Example 7

[0088] Dissolve 1 equivalent (2 mmol) of chloroaromatic aldehyde oxime 3c and 5% mmol of copper acetate dihydrate in 15 ml of 1,4-dioxane. Add 1.5 equivalents of triethylamine (3 mmol) under nitrogen atmosphere. Stir at room temperature for 15 min to produce a large amount of light blue solid. Then slowly add 1 equivalent (2 mmol) of (E)-1-(4-chlorophenyl)ethan-1-one O-propynyl-1-yl oxime 3j in 2 ml of 1,4-dioxane solution with a syringe. After the addition is completed, heat to reflux for 2 h. TLC tracking (V 石油醚 :V 乙酸乙酯 =10:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =10:1), and recrystallized from ethanol-dichloromethane to obtain a white solid (E)-(3-(2-chloro-4,5-dimethoxyphenyl)isoxazole-5-)-methylene-(4-fluorophenyl)ethanone oxime ether 4g, 0.69g, with a yield of 85%.

[0089] The Chinese name of the compound of Example 7: (E)-(3-(2-chloro-4,5-dimethoxyphenyl)isoxazole-5-)-methylene-(4-fluorophenyl)ethanone oxime ether.

[0090] English name: (E)-1-(4-fluorophenyl)ethan-1-one O-((3-(2-chloro-4,5-dimethoxyp henyl)isoxazol-5-yl)methyl)oxime

[0091] Structural formula:

[0092]

[0093] Molecular formula: C 20 H 18 ClFN2O4 molecular weight: 404.1005;

[0094] Physical and chemical properties: white solid, melting point 76.6-74.4℃. Soluble in chloroform, ethyl acetate, acetone, methanol, ethanol, hardly soluble in water;

[0095] NMR data 1 H NMR(400MHz, CDCl3)δ7.66–7.60(m,2H,H3 or H5),7.30(s,1H,H 14 ),7.04(t,J=8.7Hz,2H,H2 or H6),6.93(s,1H,H 17 ),6.84(s,1H,H 11 ),5.32(s,2H,H9),3.90(s,6H,H 19 or H 20 ),2.26(s,3H,H8). 13 C NMR (101 MHz, CDCl3) δ 168.81 (C 10 ),163.54(d,J=249.4Hz,C1),160.87(C 12 ),155.33(C7),150.61(C 16 ),148.01(C 15 ),132.16(d,J=3.3Hz,C4),128.05(d,J=8.3Hz,C3 or C5),124.54(C 18 ),119.98(C 13 ),115.40(d,J=21.8Hz,C2 orC6),113.09(C 17 ),112.68(C 14 ),104.82(C 11 ),66.55(C9),56.20(C 19 or C 20),12.86(C8).Mass spectrum data HRESIMS:m / z 405.1005[M+H] + .

[0096] Example 8

[0097] Dissolve 1 equivalent (2 mmol) of chloroaromatic aldehyde oxime 3e and 5% mmol of copper acetate dihydrate in 15 ml of 1,4-dioxane, add 1.5 equivalents of triethylamine (3 mmol) under nitrogen atmosphere, stir at room temperature for 15 min to produce a large amount of light blue solid, then slowly add 1 equivalent (2 mmol) of (E)-1-phenylethan-1-one O-propynyl-1-yl oxime 3g in 2 ml of 1,4-dioxane solution with a syringe, heat under reflux for 2 h after the addition is completed, and track with thin layer chromatography (V 石油醚 :V 乙酸乙酯 =10:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =10:1), and recrystallized from ethanol-dichloromethane to obtain a white powder (E)-(3-(4-chlorophenyl)isoxazole-5-)-methylenephenyl acetone oxime ether 4h, 0.56g, with a yield of 87%.

[0098] The Chinese name of the compound of Example 8: (E)-(3-(4-chlorophenyl)isoxazole-5-)-methylenephenylethanone oxime.

[0099] English name: (E)-1-phenylethan-1-one O-((3-(4-chlorophenyl)isoxazol-5-yl)meth yl)oxime

[0100] Structural formula:

[0101]

[0102] Molecular formula: C 18 H 15 ClN2O4 molecular weight: 326.08807;

[0103] Physical and chemical properties: white crystals, melting point 81.5-81.9°C. Soluble in chloroform, ethyl acetate, acetone, methanol, ethanol, and insoluble in water;

[0104] NMR data 1 H NMR (500MHz, CDCl3) δ7.75 (d, J = 7.2Hz, 2H, H 14 or H 18),7.65(m,2H,H3 or H5),7.42(d,J=7.2Hz,2H,H 15 or H 17 ),7.40–7.34(m,3H,H2,H5and H1),6.58(s,1H,H 11 ),5.33(s,2H,H9),2.29(s,3H,H8). 13 C NMR (126 MHz, CDCl3) δ 170.19 (C 10 ),161.45(C 12 ),156.50(C7),136.00(C4),135.96(C 16 ),129.49(C1),129.17(C 15 or C 17 ),128.47(C2or C6),128.12(C 14 or C 18 ),127.52(C 13 ),126.17(C3 or C5),101.24(C 11 ), 66.61(C9), 12.92(C8). Mass spectral data HRESIMS: m / z 327.08807[M+H] + .

[0105] Example 9

[0106] Dissolve 1 equivalent (2 mmol) of chloroaromatic aldehyde oxime 3e and 5% mmol of copper acetate dihydrate in 15 ml of 1,4-dioxane, add 1.5 equivalents of triethylamine (3 mmol) under nitrogen atmosphere, stir at room temperature for 15 min to produce a large amount of light blue solid, then slowly add 1 equivalent (2 mmol) of (E)-1-(3,4-dimethoxyphenyl)ethan-1-one O-propynyl-1-yl oxime 3i in 2 ml of 1,4-dioxane solution with a syringe, heat under reflux for 2 h after the addition is completed, and track with thin layer chromatography (V 石油醚 :V 乙酸乙酯 =10:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =10:1), and recrystallized from ethanol-dichloromethane to obtain a white powder (E)-(3-(4-chlorophenyl)isoxazole-5-)-methylene-(3,4-dimethoxyphenyl)ethanone oxime ether 4i, 0.63 g, yield 81%.

[0107] The Chinese name of the compound of Example 9: (E)-(3-(4-chlorophenyl)isoxazole-5-)-methylene-(3,4-dimethoxyphenyl)ethanone oxime.

[0108] English name: (E)-1-(3,4-dimethoxyphenyl)ethan-1-one O-((3-(4-chlorophenyl)iso xazol-5-yl)methyl)oxime

[0109] Structural formula:

[0110]

[0111] Molecular formula: C 20 H 19 ClN2O4 molecular weight: 386.1120;

[0112] Physical and chemical properties: white crystals, melting point 93.8-94.5℃. Soluble in chloroform, ethyl acetate, acetone, methanol, ethanol, hardly soluble in water;

[0113] NMR data 1 H NMR (500MHz, CDCl3) δ7.75 (d, J = 7.0Hz, 2H, H 16 or H 20 ),7.42(d,J=7.0Hz,2H,H 17 or H 19 ),7.26(d,J=1.8Hz,1H,H6),7.16(d,J=8.1Hz,1.8Hz,1H,H4),6.85(d,J=8.1Hz,1H,H3),6.58(s,1H,H 13 ),5.33(s,2H,H 11 ),3.91(s,6H,H1 or H8),2.27(s,3H,H 10 ). 13 C NMR (126MHz, CDCl3) δ170.29 (C 12 ),161.44(C 14 ),156.05(C9),150.42(C2),148.86(C7),136.02(C 18 ),129.18(C 17 or C 19 ),128.64(C5),128.09(C 16 or C 20 ),127.52(C 15),119.41(C4),110.56(C3),108.72(C6),101.15(C 13 ),66.61(C 11 ),55.93(C1 or C8),55.91(C1 or C8),12.78(C 10 ).Mass spectrum data HRESIMS: m / z 387.1120[M+H] + .

[0114] Example 10

[0115] Dissolve 1 equivalent (2 mmol) of chloroaromatic aldehyde oxime 3e and 5% mmol of copper acetate dihydrate in 15 ml of 1,4-dioxane, add 1.5 equivalents of triethylamine (2 mmol) under nitrogen atmosphere, stir at room temperature for 15 min to produce a large amount of light blue solid, then slowly add 1 equivalent (2 mmol) of (E)-1-(4-fluorophenyl)ethan-1-one O-propynyl-1-yl oxime 3k in 2 ml of 1,4-dioxane solution with a syringe, heat under reflux for 2 h after the addition is completed, and track with thin layer chromatography (V 石油醚 :V 乙酸乙酯 =10:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =10:1), to obtain a white flocculent solid (E)-(3-(4-chlorophenyl)isoxazole-5-)-methylene-(4-fluorophenyl)ethanone oxime ether 4j, 0.58 g, yield 86%.

[0116] The Chinese name of the compound of Example 10: (E)-(3-(4-chlorophenyl)isoxazole-5-)-methylene-(4-fluorophenyl)ethanone oxime ether.

[0117] English name: (E)-1-(4-fluorophenyl)ethan-1-one O-((3-(4-chlorophenyl)isoxazol-5-yl)methyl)oxime

[0118] Structural formula:

[0119]

[0120] Molecular formula: C 18 H 14 ClFN2O2 molecular weight: 344.0800;

[0121] Physical and chemical properties: White flocculent solid, melting point 97.7-98.6℃. Soluble in chloroform, ethyl acetate, acetone, methanol, ethanol, hardly soluble in water;

[0122] NMR data 1 H NMR (400MHz, CDCl3) δ7.74 (d, J = 8.7Hz, 2H, H 15 or H 17 ),7.63(dd,J=8.7,5.1Hz,2H,H3 or H5),7.41(d,J=8.7Hz,2H,H 14 or H 18 ),7.04(t,J=8.7Hz,2H,H2 or H6),6.57(s,1H,H 11 ),5.31(s,2H,H9),2.26(s,3H,H8). 13 C NMR (101 MHz, CDCl3) δ 170.08 (C 10 ),163.59(d,J=249.5Hz,C1),161.46(C 12 ),155.44(C7),136.05(C 16 ),132.08(d,J=3.3Hz,C4),129.18(C 15 or C 17 ),128.11(C 14 or C 18 ),128.05(d,J=8.3Hz,C3 or C5),127.51(C 13 )115.45(d,J=21.7Hz,C2 or C6),101.27(C 11 ), 66.61(C9), 12.86(C8). Mass spectral data HRESIMS: m / z 345.0800[M+H] + .

[0123] Embodiment 11

[0124] Dissolve 1 equivalent (2 mmol) of chloroaromatic aldehyde oxime 3f and 5% mmol of copper acetate dihydrate in 15 ml of 1,4-dioxane, add 1.5 equivalents of triethylamine (3 mmol) under nitrogen atmosphere, stir at room temperature for 15 min to produce a large amount of light blue solid, then slowly add 1 equivalent (2 mmol) of (E)-1-phenylethan-1-one O-propynyl-1-yl oxime 3g in 2 ml of 1,4-dioxane solution with a syringe, heat under reflux for 2 h after the addition is completed, and track with thin layer chromatography (V 石油醚 :V 乙酸乙酯=10:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =10:1), to obtain a white flocculent solid (E)-(3-(4-fluorophenyl)isoxazole-5-)-methylenephenyl acetone oxime ether 4k, 0.51 g, yield 83%.

[0125] The Chinese name of the compound in Example 11: (E)-(3-(4-fluorophenyl)isoxazole-5-)-methylene-phenylethanone oxime.

[0126] English name: (E)-1-phenylethan-1-one O-((3-(4-fluorophenyl)isoxazol-5-yl)meth yl)oxime.

[0127] Structural formula:

[0128]

[0129] Molecular formula: C 18 H 15 FN2O2 molecular weight: 310.1203;

[0130] Physical and chemical properties: White flocculent solid, melting point 99.8-101.2℃. Soluble in chloroform, ethyl acetate, acetone, methanol, ethanol, hardly soluble in water;

[0131] NMR data 1 H NMR (400MHz, CDCl3) δ7.78 (dd, J=8.8, 5.3Hz, 2H, H 14 or H 18 ),7.66–7.61(m,2H,H3 or H5),7.38–7.34(m,3H,H1,H2 and H6),7.12(t,J=8.8Hz,2H,H 15 H 17 ),6.56(s,1H,H 11 ),5.31(s,2H,H9),2.28(s,3H,H8). 13 C NMR (101 MHz, CDCl3) δ 170.05 (C 10 ),163.79(d,J=249.8Hz,C 16 ),161.49(C 12),156.45(C7),135.99(C4),129.47(C1),128.78(d,J=8.5Hz,C 14 or C 18 ),128.46(C2or C6),126.18(C3 or C5),125.27(d,J=3.4Hz,C 13 ),115.98(d,J=22.0Hz,C 15 or C 17 ),101.25(C 11 ), 66.62(C9), 12.87(C8). Mass spectral data HRESIMS: m / z 311.1203[M+H] + .

[0132] Example 12

[0133] Dissolve 1 equivalent (2 mmol) of chloroaromatic aldehyde oxime 3f and 5% mmol of copper acetate dihydrate in 15 ml of 1,4-dioxane, add 1.5 equivalents of triethylamine (3 mmol) under nitrogen atmosphere, stir at room temperature for 15 min to produce a large amount of light blue solid, then slowly add 1 equivalent (2 mmol) of (E)-1-(3,4-dimethoxyphenyl)ethan-1-one O-propynyl-1-yl oxime 3i in 2 ml of 1,4-dioxane solution with a syringe, heat under reflux for 2 h after the addition is completed, and track with thin layer chromatography (V 石油醚 :V 乙酸乙酯 =10:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =10:1), and recrystallized from ethanol-dichloromethane to obtain white crystals of (E)-(3-(4-fluorophenyl)isoxazole-5-)-methylene-(3,4-dimethoxyphenyl)ethanone oxime ether 4r, 0.61 g, yield 82%.

[0134] The Chinese name of the compound of Example 12: (E)-(3-(4-fluorophenyl)isoxazole-5-)-methylene-(3,4-dimethoxyphenyl)ethanone oxime ether.

[0135] English name: (E)-1-(3,4-dimethoxyphenyl)ethan-1-one O-((3-(4-fluorophenyl)iso xazol-5-yl)methyl)oxime

[0136] Structural formula:

[0137]

[0138] Molecular formula: C 20 H 19 FN2O4 molecular weight: 370.1416;

[0139] Physical and chemical properties: white crystals, melting point 97.5-98.3°C. Soluble in chloroform, ethyl acetate, acetone, methanol, ethanol, and hardly soluble in water;

[0140] NMR data 1 H NMR (400MHz, CDCl3) δ7.78 (dd, J=8.8, 5.3Hz, 2H, H 16 or H 20 ),7.28(d,J=2.1Hz,1H,H6),7.15(dd,J=8.4,2.1Hz,1H,H4),7.11(t,J=8.8Hz,2H,H 17 H 19 ),6.83(d,J=8.4Hz,1H,H3),6.56(s,1H,H 13 ),5.31(s,2H,H 11 ),3.89(s,3H,H1 or H8),3.87(s,3H,H1 or H8),2.26(s,3H,H 10 ). 13 C NMR (101 MHz, CDCl3) δ 170.16 (C 12 ),163.77(d,J=249.8Hz,C 18 ),161.46(C 14 ),155.93(C9),150.42(C2),148.88(C7),128.73(d,J=8.5Hz,C 16 or C 20 ),128.69(C5),125.27(d,J=3.3Hz,C 15 ),119.41(C4),115.98(d,J=21.9Hz,C 17 or C 19 ),110.62(C6),108.78(C3),101.17(C 13 ),66.59(C 11 ),55.88(C1 or C8),12.70(C 10 ).Mass spectrum data HRESIMS: m / z 371.1416[M+H] + .

[0141] Embodiment 13

[0142] Dissolve 1 equivalent (2 mmol) of chloroaromatic aldehyde oxime 3d and 5% mmol of copper acetate dihydrate in 15 ml of 1,4-dioxane, add 1.5 equivalents of triethylamine (3 mmol) under nitrogen atmosphere, stir at room temperature for 15 min to produce a large amount of light blue solid, then slowly add 1 equivalent (2 mmol) of (E)-1-phenylethan-1-one O-propynyl-1-yl oxime 3g in 2 ml of 1,4-dioxane solution with a syringe, heat under reflux for 2 h after the addition is completed, and track with thin layer chromatography (V 石油醚 :V 乙酸乙酯 =10:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =10:1), and recrystallized from ethanol-dichloromethane to obtain white crystals of (E)-(3-(4-methylphenyl)isoxazole-5-)-methyleneacetophenone oxime ether 4m, 0.52g, with a yield of 85%.

[0143] The Chinese name of the compound of Example 13: (E)-(3-(4-methylphenyl)isoxazole-5-)-methyleneacetophenone oxime ether.

[0144] English name: (E)-1-phenylethan-1-one O-((3-(p-tolyl)isoxazol-5-yl)methyl)oxime

[0145] Structural formula:

[0146]

[0147] Molecular formula: C 19 H 18 N2O2 molecular weight: 306.1432;

[0148] Physical and chemical properties: white solid, melting point 77.3-78.0℃. Soluble in chloroform, ethyl acetate, acetone, methanol, ethanol, hardly soluble in water;

[0149] NMR data 1 H NMR (400MHz, CDCl3) δ7.69 (d, J = 8.2Hz, 2H, H 14 or H 18 ),7.67–7.60(m,2H,H3 or H5),7.38–7.33(m,3H,H2,H6 and H1),7.23(d,J=8.2Hz,2H,H 15or H 17 ),6.57(s,1H,H 11 ),5.30(s,2H,H9),2.37(s,3H,H 19 ),2.27(s,3H,H8). 13 C NMR (101 MHz, CDCl3) δ 169.58 (C 10 ),162.34(C 12 ),156.33(C7),140.06(C 16 ),136.02(C4),129.56(C 15 or C 17 ),129.40(C1),128.43(C2 or C6),126.72(C 14 or C 18 ),126.17(C3,C5 and C 13 ),101.33(C 11 ),66.66(C9),21.39(C 19 ),12.87(C8).Mass spectrum data HRESIMS:m / z 307.1432[M+H] + .

[0150] Embodiment 14

[0151] Dissolve 1 equivalent (2 mmol) of chloroaromatic aldehyde oxime 3d and 5% mmol of copper acetate dihydrate in 15 ml of 1,4-dioxane, add 1.5 equivalents of triethylamine (3 mmol) under nitrogen atmosphere, stir at room temperature for 15 min to produce a large amount of light blue solid, then slowly add 1 equivalent (2 mmol) of (E)-1-(3,4-dimethoxyphenyl)ethan-1-one O-propynyl-1-yl oxime 3i in 2 ml of 1,4-dioxane solution with a syringe, heat under reflux for 2 h after the addition is completed, and track with thin layer chromatography (V 石油醚 :V 乙酸乙酯 =10:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =10:1), and recrystallized from ethanol-dichloromethane to obtain white crystals of (E)-(3-(4-methylphenyl)isoxazole-5-)-methylene-(3,4-dimethoxyphenyl)ethanone oxime ether 4n, 0.5 g, yield 83%.

[0152] The Chinese name of the compound of Example 14: (E)-(3-(4-methylphenyl)isoxazole-5-)-methylene-(3,4-dimethoxyphenyl)ethanone oxime ether.

[0153] English name: (E)-1-(3,4-dimethoxyphenyl)ethan-1-one O-((3-(p-tolyl)isoxazol-5-yl)methyl)oxime.

[0154] Structural formula:

[0155]

[0156] Molecular formula: C 21 H 22 N2O4 molecular weight: 366.1639;

[0157] Physical and chemical properties: white solid, melting point 126.7-127.4℃. Soluble in chloroform, ethyl acetate, acetone, methanol, ethanol, hardly soluble in water;

[0158] NMR data 1 H NMR (400MHz, CDCl3) δ7.69 (d, J = 8.2Hz, 2H, H 16 or H 20 ),7.28(d,J=2.1Hz,1H,H6),7.24(d,J=8.2Hz,2H,H 17 or H 19 ),7.15(dd,J=8.4,2.1Hz,1H,H4),6.84(d,J=8.4Hz,1H,H3),6.57(s,1H,H 13 ),5.31(s,2H,H 11 ),3.90(s,3H,H1 or H8),3.88(s,3H,H1 or H8),2.38(s,3H,H 21 ),2.26(s,3H,H 10 ). 13 C NMR (101 MHz, CDCl3) δ 169.71 (C 12 ),162.34(C 14 ),155.87(C9),150.37(C2),148.86(C7),140.09(C 18 ),129.58(C 17 or C 19 ),128.76(C5),126.70(C 16 or C 20),126.18(C 15 ),119.38(C4),110.58(C6),108.75(C3),101.25(C 13 ),66.65(C 11 ),55.90(C1 or C8),21.40(C 21 ),12.74(C 10 ).Mass spectrum data HRESIMS: m / z 367.1639[M+H] + .

[0159] Embodiment 15

[0160] 1 equivalent (2 mmol) of chloroaromatic aldehyde oxime 3d and 5% mmol of copper acetate dihydrate were dissolved in 15 ml of 1,4-dioxane. 1.5 equivalents of triethylamine (3 mmol) were added under nitrogen atmosphere. The mixture was stirred at room temperature for 15 min to produce a large amount of light blue solid. Then, 1 equivalent (2 mmol) of (E)-1-(4-chlorophenyl)ethan-1-one O-propynyl-1-yl oxime 3j in 2 ml of 1,4-dioxane was slowly added dropwise with a syringe. After the addition was completed, the mixture was heated to reflux for 2 h. The reaction mixture was followed by thin layer chromatography (V 石油醚 :V 乙酸乙酯 =10:1), after the reaction was completed, cooled to room temperature, 50 ml of water was added, 3×30 ml of ethyl acetate was extracted, the organic phases were combined, washed 3 times with saturated brine, dried over anhydrous sodium sulfate for 2 h, and separated by flash chromatography column (V 石油醚 :V 乙酸乙酯 =10:1), and recrystallized from ethanol-dichloromethane to obtain white crystals of (E)-(3-(4-methylphenyl)isoxazole-5-)-methylene-(4-chlorophenyl)ethanone oxime ether 4o, 0.58 g, yield 86%.

[0161] The Chinese name of the compound of Example 15: (E)-(3-(4-methylphenyl)isoxazole-5-)-methylene-(4-chlorophenyl)ethanone oxime.

[0162] English name: (E)-1-(4-chlorophenyl)ethan-1-one O-((3-(p-tolyl)isoxazol-5-yl)m ethyl)oxime

[0163] Structural formula:

[0164]

[0165] Molecular formula: C 19 H 17 N2O2 molecular weight: 340.10361;

[0166] Physical and chemical properties: White needle-shaped crystals, melting point 102.4-103.1°C. Soluble in chloroform, ethyl acetate, acetone, methanol, ethanol, and insoluble in water;

[0167] NMR data 1 H NMR (400MHz, CDCl3) δ7.69 (d, J = 8.2Hz, 2H, H 14 or H 18 ),7.57(d,J=8.6Hz,2H,H3 or H5),7.32(d,J=8.6Hz,2H,H2 or H6),7.24(d,J=8.2Hz,2H,H 15 H 17 ),6.56(s,1H,H 11 ),5.30(s,2H,H9),2.38(s,3H,H 19 ),2.24(s,3H,H8). 13 C NMR (101 MHz, CDCl3) δ 169.37 (C 10 ),162.37(C 12 ),155.22(C7),140.14(C 16 ),135.43(C1),134.43(C4),129.59(C 16 or C 17 ),128.63(C2 or C6),127.44(C3 or C5),126.72(C 14 or C 18 ),126.12(C 13 ),101.42(C 11 ),66.71(C9),21.40(C 19 ),12.69(C8).Mass spectrum data HRESIMS:m / z 341.10361[M+H] + .

[0168] Test example: In vitro anti-HBV test

[0169] In order to study the anti-HBV activity of the compounds obtained in Examples 1 to 15, the toxicity of the compounds to HepG2 2.2.15 cells and the inhibition of HBsAg and HBeAg were investigated by in vitro tests.

[0170] The DMEM medium used to culture HepG2 2.2.15 cells is a solution containing 10% fetal bovine serum, 0.03% glutamine, 380 μg / ml of G418 and 50 μg / ml of kanamycin. The culture conditions are 37°C and 5% CO2. The culture medium is changed every 2-3 days and the cells are subcultured every 4-5 days. (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether compounds are prepared into mother solutions with dimethyl sulfoxide, stored at 4°C, and prepared into the required concentration with DMEM medium before use.

[0171] Prepare 100 μL of HepG2.2.15 cell suspension in a 96-well plate, and place the cell culture plate in an incubator for pre-culture for 24 hours (conditions are 37°C, 5% CO2). Add 10 μL of the test drug with different concentration gradients to the pre-treated culture plate. Place the cell culture plate after administration in an incubator for incubation for 3 days. After collecting the culture medium on the 3rd day, add the culture medium containing CCK-8 solution to the cell culture plate (be careful to prevent the formation of bubbles to avoid affecting the determination of OD value). After adding CCK-8 culture medium, place the cell culture plate in an incubator for incubation for 3 hours, and take it out to detect the absorbance at 450nm with an enzyme marker. Compare with the control group (cell survival rate 100%), calculate the cell survival rate of each well to determine the cytotoxic effect of the drug.

[0172] The concentration was 1×10 4 / mL of HepG 2.2.15 cells were inoculated onto a 96-well cell culture plate and cultured for 24 hours. The target product was dissolved in a serum-free medium, and after sterile filtration, it was diluted to a concentration of 600, 300, 150, 75, and 37.5 mg / L. While ensuring the same conditions, 1% DMSO was added to the serum-free medium as a negative control group, and the lamivudine (3TC) group was used as a positive control group. The culture fluid on the cell culture plate where cells were cultured for 24 hours was aspirated, and the diluted solution was added, with 3 wells added for each concentration gradient. After culturing for 3 days, 6 days, and 9 days after drug addition, the supernatant was taken and the content of HBsAg and HBeAg in the supernatant was detected by ELISA.

[0173] The results showed that all (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether derivatives showed low toxicity. Table 1 shows the inhibitory effects of the compounds on HBeAg and HBsAg. Table 2 shows the in vitro anti-HBV activity of the compounds.

[0174] Table 1 Inhibitory effects of compounds on HBsAg and HBeAg expression in hepG2.2.15 cells at 3, 6, and 9 days

[0175]

[0176]

[0177]

[0178] Table 2 In vitro anti-HBV activity of compounds

[0179]

Claims

1. (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether derivatives with anti-hepatitis B activity, characterized in that One of the following compounds:

2. Use of the (E)-(3-phenylisoxazole-5-)-methyleneacetophenone oxime ether derivatives according to claim 1 in the preparation of anti-hepatitis B virus drugs.